Akums Drugs & Pharmaceuticals Ltd.
AKUMS
Rank in Stocks
#7769
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in... Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Share Price
$7.66
Last synced: 2026-11-16
Market Cap
$1.17B
Change (1 day)
-2.75%
Change (1 year)
62.87%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
Category
Healthcare
EPS for Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
EPS as of September 2026 TTM: $0.25
According to Akums Drugs & Pharmaceuticals Ltd.'s latest financial reports, its current EPS (TTM) is $0.25. At the end of 2025 the company had an EPS of $0.26, an increase over its 2024 EPS of 0.00.
EPS history for Akums Drugs & Pharmaceuticals Ltd. from 2022 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.25 | -3.04% |
| 2025 | $0.26 | -7,870.59% |
| 2024 | 0.00 | -104.63% |
| 2023 | $0.07 | -134.74% |
| 2022 | $-0.21 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 2,291.87% |
DE
|
|
| $6.01 | 2,283.10% |
DE
|
|
| $1.53 | 508.05% |
JP
|
|
| $3.66 | 1,351.80% |
CH
|
|
| $0.45 | 78.50% |
IL
|
Questions about Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS)
What is Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS)?
Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) over the last twelve months is $0.25, as of Sep 2026.
What was Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) in 2025?
In 2025, Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) was $0.26, compared with 0.00 in 2024.
How has Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) changed since 2022?
From 2022 to 2025, Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) was highest in 2025 ($0.26) and lowest in 2022 ($-0.21).
How does Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) compare with similar companies?
Akums Drugs & Pharmaceuticals Ltd.'s earnings per share (EPS) ($0.25) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.